The only thing I worry about the AGUOA in the short term is liquidity. But most people wouldn't be buying oppies for the short term.Nevertheless, I reckon this one's still well under the radar. The chart is certainly looking great.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor